Skip to content
Search

Latest Stories

New survey reveals alarming trends in NHS staff morale and retention

New survey reveals alarming trends in NHS staff morale and retention
14 per cent NHS Staff actively applying for non-NHS positions due to "exhaustion", "burnout" and "lack of desired pay"

A recent survey report conducted by the University of Bath Institute for Policy Research (IPR) has unveiled concerning statistics regarding the morale and retention of frontline staff, painting a bleak picture of the current state of the healthcare system.

The report, titled Should I stay or should I go? Monitoring influences on NHS staff retention in the post-COVID-19 world highlights a significant exodus of staff seeking opportunities outside the NHS, citing reasons such as psychological stress, workload, staff shortages, and notably, inadequate pay.


Between March 2023 and June 2023, nearly half of frontline NHS staff (47 per cent) explored job listings outside the NHS, with 14 per cent actively applying for non-NHS positions.

The primary motivation for seeking alternative employment was the desire for higher pay, with 23 per cent of applicants specifically seeking supplementary paid work in addition to their NHS roles.

The survey also revealed a troubling rise in symptoms of burnout among NHS staff, with half reporting feeling 'very tired or drained' most days.

Intrinsic job satisfaction and personal commitment to the NHS have steadily declined since 2020, while confidence in the improvement of working conditions remains low.

Furthermore, the report highlights a staggering decline in staff willingness to recommend NHS employment to others, with only a quarter of nurses endorsing the idea.

Testimonies from frontline workers underscore the severity of the situation, with many describing feelings of emotional exhaustion and despair.

Lead researcher Dr. Andrew Weyman expressed deep concern over the findings, emphasizing the urgent need for action to address issues such as pay, staffing levels, workload, and government recognition.

Staff identified these factors as top priorities for improving retention rates within the NHS.

In response Danny Mortimer, chief executive of NHS Employers, a part of the NHS Confederation, emphasized the critical role of NHS staff in delivering consistent care to patients and communities.

He acknowledged the stress and burnout experienced by staff, particularly in the aftermath of the pandemic, amidst continuous demands for care and noted a positive trend in the most recent NHS staff survey, indicating an overall improvement in staff experience, although disparities persist, notably among BME (Black and Minority Ethnic) staff.

"Research like this, incorporating insights from frontline workers, is invaluable in shaping future policy and strategy decisions," Mortimer remarked.

NHS Employers, he affirmed, is committed to supporting employers in these areas, aligning efforts with the NHS People Promise and the Long Term Workforce Plan unveiled the previous year.

Furthermore, UNISON's Helga Pile addressed the University of Bath's findings, noting NHS workers' inclination towards non-healthcare jobs due to low wages.

"Supermarkets are paying higher rates and can offer staff discounts and much less stressful jobs."

She urged for prompt pay raises to retain staff, stating proper NHS investment is crucial to relieve pressure and maintain quality patient care.

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less